Aktis Oncology, Inc. · NASDAQ:AKTS
Herrmann Ken sold 3,065 Aktis Oncology, Inc. shares (Form 4)
Traded Jul 17, 2026 · Filed Jul 20, 2026
On Jul 17, 2026, Herrmann Ken (Director) sold 3,065 Aktis Oncology, Inc. shares at US$25.21 for US$77,269, leaving 0 shares. Filed Jul 20, 2026 (Form 4).
- Sold
- 3,065 shares
- Price
- US$25.21
- Value
- US$77,269
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | Common Stock | Option exercise | 3,065 | US$0.08 | 3,065 | Direct |
| Jul 17, 2026 | Common Stock | Sale | 3,065 | US$25.21 | 0 | Direct |
Source
Related
- Aktis Oncology, Inc.
- Herrmann Ken
- Aktis Oncology, Inc. shareholders
- Form 4 · Herrmann Ken · Jul 21, 2026
- Form 4 · Czibere Akos · Sep 24, 2026
- Form 4 · Ron-Bigger Shulamit · Jul 10, 2026
- Form 4 · Czibere Akos · Jul 10, 2026
- Schedule 13G · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13D · EcoR1 Capital, LLC · Jan 20, 2026